Guest column : The ‘sin’ that led to an #FDA inspection #pharma #quality

You can imagine the trepidation of a pharmaceutical company when the US Food & Drug Administration (FDA) comes calling. Given the demanding nature of inspections, recent enforcement actions and the public scrutiny that each warning letter is subjected to, even a battle-ready manufacturing site with the most stouthearted management can't help but feel a ripple … Continue reading Guest column : The ‘sin’ that led to an #FDA inspection #pharma #quality

Advertisement